Evidence map›Paper›PMID 40934460›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Ergin Aydemir, Nejat Emre Öksüz, Kadriye Bir Yücel

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Reply to: "Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ergin AydemirErgin Aydemir, MD, Department of Medical Oncology, Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey; Nejat Emre Öksüz, MD, Department of Medical Oncology, Ankara University, Ankara, Turkey; and Kadriye Bir Yücel, MD, Department of Medical Oncology, Etlik City Hospital, Ankara, Turkey.ORCID 0000-0003-0498-6308
Nejat Emre ÖksüzErgin Aydemir, MD, Department of Medical Oncology, Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey; Nejat Emre Öksüz, MD, Department of Medical Oncology, Ankara University, Ankara, Turkey; and Kadriye Bir Yücel, MD, Department of Medical Oncology, Etlik City Hospital, Ankara, Turkey.ORCID 0009-0005-3831-1466
Kadriye Bir YücelErgin Aydemir, MD, Department of Medical Oncology, Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey; Nejat Emre Öksüz, MD, Department of Medical Oncology, Ankara University, Ankara, Turkey; and Kadriye Bir Yücel, MD, Department of Medical Oncology, Etlik City Hospital, Ankara, Turkey.ORCID 0000-0002-4745-1605

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40934460
PMCPMC12655861

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.